临床肝胆病杂志2018，Vol.34Issue(2)：227-228,2.DOI:10.3969/j.issn.1001-5256.2018.02.001
慢性丙型肝炎清除病毒后疾病进展风险评估
A risk assessment of disease progression after virus elimination with chronic hepatitis C
王琴 1罗碧芬 1魏来1
作者信息
- 1. 北京大学人民医院,北京大学肝病研究所,北京100044
- 折叠
摘要
Abstract
With reference to various clinical studies on interferon-α and pegylated interferon-α around the world,patients with chronic hepatitis C who receive antiviral therapy and achieve the elimination of hepatitis C virus may have significant relief or even reversion of liver fibrosis,as well as reductions in the incidence rates of decompensated liver cirrhosis,related complications,and hepatocellular carcinoma and an increase in survival rate.关键词
肝炎,丙型,慢性/肝硬化/癌,肝细胞/干扰素α/危险因素/述评Key words
hepatitis C, chronic/liver cirrhosis/carcinoma, hepatocellular/interferon-alpha/risk factors/editorial分类
医药卫生引用本文复制引用
王琴,罗碧芬,魏来..慢性丙型肝炎清除病毒后疾病进展风险评估[J].临床肝胆病杂志,2018,34(2):227-228,2.
